Mo1279 Durability of Benefit in IBS-D Patients Responding to a 2-Week Course of Rifaximin: Results From TARGET 3

Title
Mo1279 Durability of Benefit in IBS-D Patients Responding to a 2-Week Course of Rifaximin: Results From TARGET 3
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume 148, Issue 4, Pages S-658-S-659
Publisher
Elsevier BV
Online
2015-04-27
DOI
10.1016/s0016-5085(15)32224-1

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started